# Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody–positive individuals

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/aspirin-for-primary-thrombosis-prevention-in-the-antiphospholipid-syndrome-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Doruk Erkan,Melanie J. Harrison,Roger A. Levy,Margaret G. E. Peterson,Michelle Petri,Lisa R. Sammaritano,Aynur Ünalp–Arida,Verônica Silva Vilela,Yusuf Yazıcı,Michael D. Lockshin |
| Citations | 401 |
| DOI | 10.1002/art.22663 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2068492012 |
| PMID | 17599766 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Lisa R. Sammaritano](https://scholariq.org/researchers/lisa-r-sammaritano/)
- [Roger A. Levy](https://scholariq.org/researchers/roger-a-levy/)
- [Michelle Petri](https://scholariq.org/researchers/michelle-petri/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.